Reckitt: Durex condom maker strips back costs as profit inches up Retail Consumer goods giant Reckitt posted a bump to revenue in the last financial year as its cost overhaul strategy to focus on specific divisions ramped up. The blue-chip firm – which owns a massive portfolio of brands including Dettol, Durex, Lysol, Finish, Vanish, and Gaviscon – recorded a 5.2 per cent increase in revenue, driven [...]
Dettol and Nurofen owner Reckitt to sell divisions as it slims down Retail Dettol, Lysol, Durex, and Nurofen owner Reckitt has delivered a mixed financial performance for 2024, with modest like-for-like revenue growth and increased profitability but a decline in reported net revenue due to foreign exchange impacts. Like-for-like net revenue rose 1.4 per cent, driven by gains in Hygiene and Health, while Nutrition declined. Hygiene and Health [...]
Reckitt: FTSE 100 giant’s revenue slides amid restructuring Retail Reckitt has reported a drop in like-for-like revenue as the company continues to struggle after the pandemic. For the third quarter the company reported like-for-like net revenue growth of -0.5 per cent, although revenue increased 0.4 per cent for the year to 30 September. Overall, the group reported a net revenue decline of four per [...]
Market shrugs at Durex owner Reckitt’s growth and simplification plan July 24, 2024 Durex condom maker Reckitt Benckiser has pledged to sell off its home care and nutrition brands as part of a simplification drive, instead focusing on health and hygiene.
Reckitt Benckiser: Nutrition arm bruised amid baby formula litigation case April 24, 2024 Like-for-like sales at its nutrition arm fell by 9.9 per cent to £591m, which more than offset growth of 7.1 per cent at its hygiene arm and one per cent at its health arm.
Reckitt: Growth for Durex owner as it welcomes new CEO April 26, 2023 Durex maker Reckitt Benckiser reported strong revenue growth in the first leg of the year as the consumer goods giant revealed a new chief executive to lead the group. The cleaning products to sexual health company posted like-for-like revenue growth of £3.9bn up 7.9 per cent in the same period last year, as the group [...]